Tag: patent litigation
Recent Patent Cases and Generic Delays: 2023-2025 Examples
by TexTheme in Healthcare
11 Mar 2026
Despite FDA approval, many generic drugs face multi-year delays due to patent litigation. Between 2023 and 2025, patent thickets extended monopolies by an average of 3.7 years, costing patients billions and creating widespread drug shortages.
Recent Patent Cases and Generic Delays: 2023-2025 Examples
by TexTheme in Healthcare
11 Mar 2026
Between 2023 and 2025, FDA-approved generic drugs faced average delays of 3.2 years before reaching patients due to patent litigation. This article breaks down how brand companies use patent thickets to block competition - and who pays the price.
30-Month Stay: How Litigation Delays Generic Drug Approval
by TexTheme in Healthcare
8 Dec 2025
The 30-month stay under the Hatch-Waxman Act delays generic drug approval by freezing FDA action during patent lawsuits. While meant to protect innovation, it's often used to extend monopolies, costing patients billions annually.